| EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers M Garofalo, G Romano, G Di Leva, G Nuovo, YJ Jeon, A Ngankeu, J Sun, ... Nature medicine 18 (1), 74-82, 2012 | 407 | 2012 |
| MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer N Valeri, C Braconi, P Gasparini, C Murgia, A Lampis, V Paulus-Hock, ... Cancer cell 25 (4), 469-483, 2014 | 258 | 2014 |
| The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs M Boi, E Gaudio, P Bonetti, I Kwee, E Bernasconi, C Tarantelli, A Rinaldi, ... Clinical Cancer Research 21 (7), 1628-1638, 2015 | 186 | 2015 |
| MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation G Romano, M Acunzo, M Garofalo, G Di Leva, L Cascione, C Zanca, ... Proceedings of the National Academy of Sciences 109 (41), 16570-16575, 2012 | 175 | 2012 |
| Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer L Cascione, P Gasparini, F Lovat, S Carasi, A Pulvirenti, A Ferro, H Alder, ... PloS one 8 (2), e55910, 2013 | 156 | 2013 |
| Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation P Gasparini, F Lovat, M Fassan, L Casadei, L Cascione, NK Jacob, ... Proceedings of the National Academy of Sciences 111 (12), 4536-4541, 2014 | 153 | 2014 |
| microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers P Gasparini, L Cascione, M Fassan, F Lovat, G Guler, S Balci, C Irkkan, ... Oncotarget 5 (5), 1174, 2014 | 138 | 2014 |
| Regulation of acute graft-versus-host disease by microRNA-155 P Ranganathan, CEA Heaphy, S Costinean, N Stauffer, C Na, ... Blood, The Journal of the American Society of Hematology 119 (20), 4786-4797, 2012 | 131 | 2012 |
| In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation F Pichiorri, D Palmieri, L De Luca, J Consiglio, J You, A Rocci, T Talabere, ... Journal of Experimental Medicine 210 (5), 951-968, 2013 | 108 | 2013 |
| The genetics of nodal marginal zone lymphoma V Spina, H Khiabanian, M Messina, S Monti, L Cascione, A Bruscaggin, ... Blood, The Journal of the American Society of Hematology 128 (10), 1362-1373, 2016 | 88 | 2016 |
| A MALT lymphoma prognostic index C Thieblemont, L Cascione, A Conconi, B Kiesewetter, M Raderer, ... Blood 130 (12), 1409-1417, 2017 | 83 | 2017 |
| Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors H Janouskova, G El Tekle, E Bellini, ND Udeshi, A Rinaldi, A Ulbricht, ... Nature medicine 23 (9), 1046, 2017 | 80 | 2017 |
| Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options P Gasparini, M Fassan, L Cascione, G Guler, S Balci, C Irkkan, C Paisie, ... PLoS One 9 (2), e88525, 2014 | 80 | 2014 |
| miR-15b/16-2 deletion promotes B-cell malignancies F Lovat, M Fassan, P Gasparini, L Rizzotto, L Cascione, M Pizzi, ... Proceedings of the National Academy of Sciences 112 (37), 11636-11641, 2015 | 76 | 2015 |
| Circulating miRNA markers show promise as new prognosticators for multiple myeloma A Rocci, CC Hofmeister, S Geyer, A Stiff, M Gambella, L Cascione, J Guan, ... Leukemia 28 (9), 1922-1926, 2014 | 74* | 2014 |
| A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies A Drusco, A Bottoni, A Lagana, M Acunzo, M Fassan, L Cascione, ... Oncotarget 6 (25), 20829, 2015 | 68 | 2015 |
| microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers P Gasparini, L Cascione, L Landi, S Carasi, F Lovat, C Tibaldi, G Alì, ... Proceedings of the National Academy of Sciences 112 (48), 14924-14929, 2015 | 63 | 2015 |
| TWIST1-induced miR-424 reversibly drives mesenchymal programming while inhibiting tumor initiation DJ Drasin, AL Guarnieri, D Neelakantan, J Kim, JH Cabrera, CA Wang, ... Cancer research 75 (9), 1908-1921, 2015 | 57 | 2015 |
| Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression R Galli, A Paone, M Fabbri, N Zanesi, F Calore, L Cascione, M Acunzo, ... Proceedings of the National Academy of Sciences 110 (24), 9812-9817, 2013 | 55 | 2013 |
| Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma R Chilà, A Basana, M Lupi, F Guffanti, E Gaudio, A Rinaldi, L Cascione, ... Oncotarget 6 (5), 3394, 2015 | 53 | 2015 |
Matteo FassanUniversity of PaduaVerified email at bz.omceo.it
